Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Employees American Society for Pharmacology and Experimental Therapeutics Inc. Richard Dodenhoff

Richard Dodenhoff

Key employee

Journals Director at American Society for Pharmacology and Experimental Therapeutics Inc.

Fiscal year ended December 31, 2020. Published on January 24, 2026.

$209,922
2020

Total compensation

Richard Dodenhoff has been listed as an employee of American Society for Pharmacology and Experimental Therapeutics Inc. in Form 990 filings since at least fiscal year 2016. Total compensation for Richard Dodenhoff has increased by 19.9% from 2016 to 2020.

Annual compensation details

$209,922
+9.5%
Journals Director
2020
$182k
40 hrs/wk
$28k
--
$191,767
+1.7%
Journals Director
2019
$167k
40 hrs/wk
$26k
--
$188,513
+4.2%
Journals Director
2018
$164k
40 hrs/wk
$25k
--
$180,841
+3.3%
Journals Director
2017
$157k
40 hrs/wk
$25k
--
$175,147
Journals Director
2016
$152k
40 hrs/wk
$24k
--

Total compensation by year

Compare the compensation of Richard Dodenhoff to:

Revisions to this profile

January 24, 2026:
2020 American Society for Pharmacology and Experimental Therapeutics Inc. 990 published
January 24, 2026:
2019 American Society for Pharmacology and Experimental Therapeutics Inc. 990 published
January 24, 2026:
2018 American Society for Pharmacology and Experimental Therapeutics Inc. 990 published

Get an email update when compensation for Richard Dodenhoff is updated

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →
2020

Other employees at American Society for Pharmacology and Experimental Therapeutics Inc.

Judith Siuciak
Executive Director
$297,547
$267,864 No related comp$29,683
Matthew Hilliker
Chief Financial Officer
$158,591
$135,021 No related comp$23,570
Suzie Thompson
Marketing Director
$153,818
$118,575 No related comp$35,243
Melissa Huston
Meetings Director
$147,383
$113,134 No related comp$34,249
Catherine Fry
Education Director
$141,005
$119,164 No related comp$21,841
Christopher Keene
Content Licensing and Sales
$120,425
$108,677 No related comp$11,748